Pfizer announces net profit of $866m in 3rd quarter


2 Nov 2010

Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Pin on PinterestShare on RedditEmail this to someone

Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Pin on PinterestShare on RedditEmail this to someone

Pfizer has announced third-quarter net profits of $866m (€618m), representing a 70pc drop from the same time last year.

Pfizer has announced that third-quarter 2010 revenues amounted to $16.2bn – an increase of 39pc compared with $11.6bn in the year-ago quarter.  

Pfizer reported net income of $866m (€618m), a decrease of 70pc compared with $2.9bn in the prior-year quarter.

The company’s revenues for third-quarter 2010 were favourably impacted, compared with the same time last year, by $5.2bn, or 44pc.

The addition of the legacy Wyeth products were attributed to the drop from last year’s profits and negatively impacted the company to the tune of $458m, or 4pc.  

US revenues remained high at $7.1bn – an increase of 48pc compared with a year ago, while international revenues performed better – $9.1bn, or an increase of 33pc compared to this time last year.